Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Pediatr. 2016 Dec 9;182:375–377.e2. doi: 10.1016/j.jpeds.2016.11.043

The Effect of Skin Pigmentation on the Accuracy of Pulse Oximetry in Infants with Hypoxemia

Elizabeth E Foglia 1,2, Robin K Whyte 3, Aasma Chaudhary 2, Antonio Mott 4, Jodi Chen 5, Kathleen J Propert 6, Barbara Schmidt 1,2,6
PMCID: PMC5328979  NIHMSID: NIHMS835644  PMID: 27939107

Abstract

To compare pulse oximetry measurement bias between infants with hypoxemia with either dark skin or light skin with Masimo Radical 7 and Nellcor Oximax. There was no significant difference in systematic bias based on skin pigment for either oximeter.


Pulse oximetry provides a safe and noninvasive method to monitor arterial oxygen saturation (SaO2) levels continuously in children who are critically ill.1 Studies of adults have demonstrated that pulse oximetry oxygen saturation (SpO2) consistently overestimates measured SaO2 in individuals with hypoxemia who have dark skin.2,3 The impact of skin pigmentation on the accuracy of pulse oximetry in infants with hypoxemia is unknown.

The primary study objective was to compare the bias in pulse oximetry measurement between infants with hypoxemia with either dark skin or light skin. The secondary objective was to determine the accuracy and precision of 2 commonly used oximeters from 2 different manufacturers in infants with hypoxemia.

Methods

This was a prospective, cross-sectional study conducted at the Children’s Hospital of Philadelphia. Infants were enrolled with cyanotic congenital heart disease and baseline oxygen saturation <90% and an indwelling arterial line; we excluded infants with elevated methemoglobin levels, hypotension, or anemia. Each subject was only enrolled once. Written informed consent for study participation was obtained from eligible infants’ parents. This study was conducted with approval from the institutional review board of Children’s Hospital of Philadelphia.

Arterial co-oximetry samples were analyzed with the Siemens Rapidlab 1265 (Siemens Healthcare, Erlangen, Germany). The Rapidlab uses a polychromator to measure light absorbance at several wavelengths from human blood to detect and quantify total hemoglobin and its derivatives. According to the manufacturer, fetal hemoglobin (tested at 20%, 40%, and 85% levels) does not interfere with oxyhemoglobin or deoxyhemoglobin measurement results.4

Pulse oximetry was measured simultaneously with 2 oximeters. The Nellcor Oximax (Covidien, Boulder, Colorado) was used clinically in conjunction with the GE Solar 8000 patient monitor (Version 5.4,Neonatal ICU mode; GE Healthcare, Little Chalfont, United Kingdom) with an averaging time of 6 seconds. In addition, a study-specific Masimo Rainbow SET Radical 7, (V7.9.1.0, with LNOP sensor; Masimo Corp, Irvine, California), was programmed with an averaging time of 10 seconds.

The pulse oximeter sensors were placed on the infant’s extremities under the observation of operational rules to prevent a differential from right to left or bidirectional shunting across the ductus arteriosus. An opaque blanket was placed over the pulse oximeter sensors, and a study team member confirmed pulse oximetry measurement stability and signal quality. The study team member recorded the displayed pulse oximetry measurement at the same time that an arterial blood sample was obtained from an indwelling arterial catheter. The blood sample was sent immediately to the hospital laboratory for cooximetry measurement by technicians who were not connected with the study team.

Baseline demographic data and clinical variables that could affect pulse oximetry accuracy were extracted from the medical record. Consistent with previous studies,5,6 skin pigment group was allocated with the Munsell System Soil Color Chart (2009 Revision, Munsell Color, Grand Rapids, Michigan),Hue 7.5YR (Figure 1; available at www.jpeds.com). The value score that best matched the subject’s skin on the dorsal surface of the distal extremities was recorded.

Figure 1.

Figure 1

Munsell Soil Book of Color, Hue 7.5YR used to designate pigment group. Light pigment included values 7 and 8. Dark pigment included values 5, 4, 3, and 2.5. Value 6 was considered intermediate and not classified as light or dark. Image reproduced with permission from Munsell Color of X-Rite Pantone inc. (Grand Rapids, Michigan).

As described previously,7 the accuracy and precision of the pulse oximeters were assessed with the following terms. Bias was defined as SpO2-SaO2 for a given pair of measurements in a subject. Precision was defined as 1 SD of the mean distance between individual data points (plotted SpO2 vs SaO2) and the best-fit line. Accuracy root mean square (Arms) accounts for both the accuracy and precision of pulse oximetry measurement. Arms is calculated as follows:

Arms=i=1N(SpO2iSaO2i)2n

The US Food and Drug Administration requires that pulse oximeters have Arms ≤3% in SpO2 range from 70% to 100%,8 in conformance with the International Organization of Standardization. Arms were calculated for all measurements and for measurements when SaO2 ≥70%.

Using Stata 14.0 (StataCorp, College Station, Texas), we assessed differences between groups with light and dark pigment for continuous variables using t test (parametric) and the Wilcoxon rank sum test (nonparametric). For dichotomous variables, the χ2 test and Fisher exact test were used as appropriate. Differences in bias were compared between groups with light and dark pigment (Student t test) and between oximeters (paired t test). Linear regression was used to control for baseline characteristics that significantly differed between pigment groups in univariable analysis with P value < .05. The study had 80% power to detect 1 SD difference in measurement bias between pigment groups.

Results

Between April 25, 2013, and December 23, 2015, 101 infants were screened, and 36 were enrolled (Figure 2; available at www.jpeds.com). There were 21 infants in the group with light pigment and 14 infants in the group with dark pigment. One infant was classified as intermediate pigment (these data were not included in the skin pigment analysis but were included in the assessment of accuracy). Two Nellcor measurements from the group with light pigment were excluded (one because of concern for right-to-left shunting across the ductus arteriosus and one for poor signal quality).

Figure 2.

Figure 2

Study screening and enrollment flow diagram.

The group with dark pigment was significantly older at the time of the procedure and had a greater mean arterial blood pressure. Infants were not hypothermic, hypotensive, acidotic, or anemic at the time of the procedure (Table). Measured SaO2 values ranged from 60% to 92%.Measurement bias did not differ significantly between groups with light and dark pigment for either oximeter, with or without adjustment for age at the time of the procedure and mean arterial blood pressure (Table).

Table.

Baseline characteristics and measurement bias according to skin pigment

Light pigment (n = 21) Dark pigment (n = 14) P value
Demographic characteristics
Gestational ages, wk, median (IQR) 39 (38, 40) 38 (37, 39) .19
Ages at procedure, d, median (IQR) 6 (5, 66) 118 (80, 141) <.001
Males 14 (67%) 7 (50%) .32
Exposure to exogenous red blood cells 16 (76%) 14 (100%) .07
Hemoglobinopathy 0 1 (7%): Hemoglobin FAS .40
Diagnoses .99
  Hypoplastic left heart 7 6
  Tetralogy of Fallot 3 1
  Pulmonary atresia 4 2
  Tricuspid atresia 1 1
  Truncus arteriosus 1 1
  Transposition of the great arteries 1 1
  Double outlet right ventricle 1 1
  Pulmonic stenosis 1 1
  Other 2 0
Clinical characteristics at procedure
Hemoglobin, g/dL, mean (SD) 14.5 (1.4) 13.8 (1.9) .23
pH, mean (SD) 7.4 (0.1) 7.4 (0.1) .73
Skin temperature, °C, mean (SD) 37.0 (0.5) 36.9 (0.6) .49
Mean arterial blood pressure, mm Hg, mean (SD) 55 (14) 67 (12) .01
Milrinone 10 (48%) 7 (50%) .89
Dopamine 2 (10%) 0 .51
Measurement biases, mean (SD)
Masimo Radical 7 0.2% (3.8%) (n = 21) 1.6% (4.8%) (n = 14) .39*
Nellcor Oximax 3.0% (5.0%) (n = 19) 5.4% (5.1%) (n = 14) .39*
*

Adjusted in linear regression for postnatal age at procedure and mean arterial blood pressure.

The mean Masimo measurement bias was 0.8% (SD 4.2%). The precision of Masimo measurement was 2.4%, and calculated Arms was 4.2%. For 32 measurements with SaO2 values ≥70%, the calculated Arms was 4.2%. The mean measurement bias for the Nellcor was 3.9% (SD 5.0%), and the precision (SD) was 2.0%. The calculated Nellcor Arms for all subjects was 6.3%. For 30 measurements with SaO2 values ≥70%, the calculated Nellcor Arms was 5.4%. Mean Nellcor bias was significantly greater than Masimo bias, P = .0005 (Figure 3; available at www.jpeds.com).

Figure 3.

Figure 3

SpO2 vs SaO2 for Masimo (top) and Nellcor (bottom) oximeters with line of equity (solid) and fitted line (dashed). Solid circles indicate dark skin pigment and open circles indicate light skin pigment.

Discussion

We undertook this study to evaluate pulse oximetry performance under 2 conditions: hypoxemia and darkly pigmented skin. We did not find evidence of systematic bias in pulse oximetry measurement based on skin pigmentation in infants with hypoxemia. We were able to study this question by enrolling children with cyanotic congenital heart disease and stable hypoxemic physiology. Within a broad range of oxygen saturations from 60% to 92%, we did not find evidence of a systematic difference in the degree of bias in pulse oximetry measurement based on skin pigment.

Using Arms, a combined assessment of accuracy and precision, we found that the calculated Arms of both oximeters were greater than 3% (the US Food and Drug Administration requirement), even when we restricted our analysis to infants with SaO2 values ≥70%. Furthermore, we found that the Nellcor Oximax systematically overestimated measured SaO2 in infants with hypoxemia. Other investigators also have demonstrated that pulse oximetry overestimates measured arterial saturation in infants with hypoxemia.9 These findings suggest that pulse oximetry manufacturers should improve their algorithms for children with cyanosis.

Pulse oximetry is recommended to monitor infants immediately after birth during the transition from hypoxemia to normoxia.10 Furthermore, pulse oximetry is used to monitor infants with cyanotic heart disease in the hospital, and home monitoring is now used for interstage monitoring of infants with hypoplastic left heart syndrome.11 Clinicians should be aware of the limitations of pulse oximetry performance in infants with hypoxemia and interpret absolute SpO2 values obtained by pulse oximetry cautiously in infants with hypoxemia.

This study is limited by its relatively small sample size. In addition, the Nellcor oximeter averaging time was specified by the clinical unit and was slightly shorter than the Masimo averaging time; however, we obtained these samples in infants with stable SpO2 values for the 2 minutes immediately preceding arterial sampling. A small difference in averaging time is therefore unlikely to influence the study results. Study strengths include the fact that we assigned pigment groups based on the skin pigment rather than relying on racial categories. In addition, we collected data about demographic and clinical characteristics that could affect the accuracy of the pulse oximeter. Last, a study team member was present during all measurements to confirm the quality of the pulse oximetry signal. Skin pigment does not lead to additional systematic bias in pulse oximetry measurement in infants with hypoxemia.

Acknowledgments

Supported by Thrasher Research Fund (Early Career Award [9222; to E.F.]) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1T32HD060550-01A1 [to E.F.]), and National Institutes of Health Loan Repayment Program (to E.F.).

Glossary

Arms

Accuracy root mean square

SaO2

Arterial oxygen saturation

SpO2

Pulse oximetry oxygen saturation

Footnotes

The authors declare no conflicts of interest.

References

  • 1.Fouzas S, Priftis KN, Anthracopoulos MB. Pulse oximetry in pediatric practice. Pediatrics. 2011;128:740–752. doi: 10.1542/peds.2011-0271. [DOI] [PubMed] [Google Scholar]
  • 2.Feiner JR, Severinghaus JW, Bickler PE. Dark skin decreases the accuracy of pulse oximeters at low oxygen saturation: the effects of oximeter probe type and gender. Anesth Analg. 2007;105:S18–S23. doi: 10.1213/01.ane.0000285988.35174.d9. [DOI] [PubMed] [Google Scholar]
  • 3.Bickler PE, Feiner JR, Severinghaus JW. Effects of skin pigmentation on pulse oximeter accuracy at low saturation. Anesthesiology. 2005;102:715–719. doi: 10.1097/00000542-200504000-00004. [DOI] [PubMed] [Google Scholar]
  • 4.Siemens Healthcare Diagnostics, Inc. Rapidlab 1200 systems operator’s guide. Malvern (PA): Siemens Healthcare Diagnostics, Inc; 2012. 02087462 Rev. W. [Google Scholar]
  • 5.Ries AL, Prewitt LM, Johnson JJ. Skin color and ear oximetry. Chest. 1989;96:287–290. doi: 10.1378/chest.96.2.287. [DOI] [PubMed] [Google Scholar]
  • 6.Adler JN, Hughes LA, Vivilecchia R, Camargo CA. Effect of skin pigmentation on pulse oximetry accuracy in the emergency department. Acad Emerg Med. 1998;5:965–970. doi: 10.1111/j.1553-2712.1998.tb02772.x. [DOI] [PubMed] [Google Scholar]
  • 7.Batchelder PB, Raley DM. Maximizing the laboratory setting for testing devices and understanding statistical output in pulse oximetry. Anesth Analg. 2007;105:S85–S94. doi: 10.1213/01.ane.0000268495.35207.ab. [DOI] [PubMed] [Google Scholar]
  • 8.US Food and Drug Administration. Pulse oximeters—premarket notification submissions [510(k)s]: guidance for industry and food and drug administration staff. [Accessed April 28, 2016]; http://www.fda.gov/RegulatoryInformation/Guidances/ucm341718.htm.
  • 9.Ross PA, Newth CJL, Khemani RG. Accuracy of pulse oximetry in children. Pediatrics. 2014;133:22–29. doi: 10.1542/peds.2013-1760. [DOI] [PubMed] [Google Scholar]
  • 10.Perlman JM, Wyllie J, Kattwinkel J, Wyckoff MH, Aziz K, Guinsburg R, et al. Part 7: neonatal resuscitation: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation. 2015;132:S204–S241. doi: 10.1161/CIR.0000000000000276. [DOI] [PubMed] [Google Scholar]
  • 11.Oster ME, Ehrlich A, King E, Petit CJ, Clabby M, Smith S, et al. Association of interstage home monitoring with mortality, readmissions, and weight gain: a multicenter study from the national pediatric cardiology quality improvement collaborative. Circulation. 2015;132:502–508. doi: 10.1161/CIRCULATIONAHA.114.014107. [DOI] [PubMed] [Google Scholar]

RESOURCES